|
|
|
Coast IRB Dissolution Plan and Future Contact Information
“Now it’s personal, without the touch”
Coast IRB Dissolution Plan:
April 14, 2009: FDA directed Coast IRB to suspend review of all new clinical trials and to suspend further enrollment of any new subjects in current trials. April 23, 2009: Coast announced that all its studies would be transferred to other IRBs in preparation of closure. Transfer actions were initiated on April 24, 2009 via email blast and telephone calls to all clients. May 28, 2009: Coast announced that all original trial records it oversees must retained by Coast for a minimum of 3 years. Upon request, copies of records can be forwarded to clients. June 3, 2009: Coast announced that it will cease operations on June 30, 2009. After June 30, 2009, Coast will administratively close any study that has not been transferred to another IRB. Additionally, Coast announced that all original records will be destroyed after 3 year retention period. Any client requesting their original records must do so prior to June 30, 2009. Coast also announced that it will hold its final official IRB meeting on June 25, 2009. July 7, 2009: Coast officially closed its transfer window and commenced with administratively closing all active trials that have not been transferred. July 14, 2009: Coast administratively closed all active trials and ceased IRB officially ceased oversight of all clinical trials. August 31, 2009: Coast IRB closes its doors.
Future Contact:All accounting and invoicing issues should be addressed to: Ms. Kelly Robison at krobison@coastirb.com All study related trial and file storage issues should be addressed to: Ms. Alyssa Kabonic at akabonic@coastirb.com All liquidation and closure issues should be addressed to: Mr. Randy Lewis at rlewis@cloyses.com
New Address:
|
|
